|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Interferon-ribavirin combination therapy for chronic hepatitis C显示文摘 | Professor Dr. Solko W. Schalm J. T. Brouwer L. Chemello A. Alberti A. Bellobuono G. Ideo R. Schwartz O. Weiland | 1996 | Digestive Diseases and Sciences1996，，12： | 1 |
| 2 | Periphereal blood levels of matrix metalloproteinase - 2 and - 9 are elevated in patients with acute coronary syndromes 显示文摘 | HISASHI K HISAO I H IDEO Y | 1998 | J Am Coll Cardiol1998，32，2： | 1 |
| 3 | Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus显示文摘 | Poynard T Mareellln P Lee SS Minuk GS Ideo G Bain V Heathcote J Zeuzem S Trepo C Albrecht J | | 0，，： | 1 |
| 4 | Color quantization using the fast k-means algorithm显示文摘 | ideo Kasuga Hiroaki Yamamoto Masayuki Okamoto | 2000 | Systesm and Computers in Japan2000，31，8： | 1 |
| 5 | Improvement of the activated sludge process byapplication o f a biocontac to r filled with humus so itpellets显示文摘 | H ideo K | 1994 | J Japan Sewage Works Association(in Japanese)1994，31，368： | 1 |
| 6 | Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C显示文摘 | Savino Bruno Pier Maria Battezzati Giorgio Bellati Aldo Manzin Marco Maggioni Andrea Crosignani Mauro Borzio Laura Solforosi Alberto Morabito Gaetano Ideo Mauro Podda | 2001 | Journal of Hepatology2001，，5： | 1 |
| 7 | Hepatitis G vires and post-transplantation hepatitis显示文摘 | Belli LS Ideo G Silini E | 1996 | N Engl J Med1996，335，： | 1 |
| 8 | A novel non-acid method for the preparation of 2,2,2-trifluoro-1-(3-nitrophenyl) ethanone and 1-nitro-3-trifluoromethylbenzene,versatile starting materials for trifluoromethyl-contraning aromatic compounds显示文摘 | Suzuki H Tatsumi A Suzuki H Ideo | 1995 | Synthesis1995，，： | 1 |
| 9 | Interferon β-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C显示文摘AIM: To compare the efficacy and safety of recombinant human IFN β-1a alone or in combination with ribavirin in treatment-na(i)ve subjects with chronic hepatitis C.METHODS: Open, randomized trial was performed in 6 Italian tertiary centers: 102 of the 108 patients screened were randomized to receive 6 MIU of recombinant human IFN β-1a subcutaneously daily for 24 wk, alone (Group 1, n = 51) or in combination with ribavirin 1 000 to 1 200 mg/d (Group 2, n = 51).RESULTS: The end-of-treatment virologic response rate was 29.4% in Group 1 and 41.2% in Group 2 (non-significant). Twenty-four weeks after stopping therapy,sustained virologic response rate was 21.6% in Group 1 and 27.4% in Group 2 (non-significant). All subjects in Group 1 completed treatment, while two subjects in Group 2 stopped therapy due to treatment-related adverse events.CONCLUSION: Recombinant human IFN β-1a, alone or in combination with ribavirin, has an excellent safety profile and, may represent an alternative for chronic hepatitis C patients who are unable to tolerate pegylated α-interferon. | Rinaldo Pellicano Antonio Craxì Piero Luigi Almasio Mario Valenza Giovanna Venezia Alfredo Alberti Silvia Boccato Luigi Demelia Orazio Sorbello Antonino Picciotto Francesco Torre Gaetano Ideo Carlo Cattaneo Mara Berrutti Mario Rizzetto | 2005 | World Journal of Gastroenterology2005，11，29： | 1 |
| 10 | Drastic therapy for listerial brain abscess involving combined hyperbaric oxygen therapy and antimicrobial agents显示文摘 | Nakahara K Yamashita S Ideo K | 2014 | J Clin Neurol2014，10，4： | 1 |
| 11 | Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization显示文摘 | G. Colella R. Bottelli L. De Carlis C. V. Sansalone G. F. Rondinara A. Alberti L. S. Belli F. Gelosa G. M. Iamoni A. Rampoldi A. De Gasperi A. Corti E. Mazza P. Aseni A. Meroni A. O. Slim M. Finzi F. Di Benedetto F. Manochehri M. L. Follini G. Ideo D. For | 1998 | Transplant International1998，，1： | 1 |
| 12 | Drastic Therapy for Listerial Brain Abscess Involving Combined Hyperbaric Oxy- gen Therapy and Antimicrobial Agents显示文摘 | Nakahara K Yamashita S Ideo K | 2014 | Journal of Clinical Neurology2014，10，4： | 1 |
| 13 | Drastic therapy for listerialbrain abscess involving combined hyperbaric oxygen therapy andantimicrobial agents显示文摘 | Nakahara K Yamashita S Ideo K | 2014 | J Clin Neurol2014，10，4： | 1 |
| 14 | Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C显示文摘 | Solko W. Schalm Bettina E. Hansen Liliana Chemello Antonio Bellobuono Johannes T. Brouwer Ole Weiland Luisa Cavalletto Robert Schvarcz Gaetano Ideo Alfredo Alberti | 1997 | Journal of Hepatology1997，，5： | 1 |
| 15 | High-temperature operation (70 C,50 mW) of 660 nm band InGaAlP Zn diffused window lasers fabricated using highly Zn doped GaAs layers显示文摘 | Minoru Watanabe H ideo Shiozawa Osamu Horiuchi | 1999 | IEEE J Select Topics Quantum Electron1999，9，： | 1 |
| 16 | Anovel non-acid method for the preparation of 2,2,2-trifluoro-1-(3-nitrophenyl) ethanone and 1-nitro-3-trifluoromethylbenzene,versatile starting materials for trifluoromethyl-contraning aromatic compounds显示文摘 | Suzuki H Tatsumi A Suzuki H Ideo | 1995 | Synthesis1995，，： | 1 |
| 17 | Portable remote methane sensor using a tunable diode laser显示文摘 | Takaya I H ideo T Kiyoshi K | 2000 | Measurement Science and Technology2000，11，6： | 1 |
| 18 | Novel O-linked glycans containing 6'-sulfo-GaL/GalNAc of MUC1 secreted from human breast Cancer YMB-S cells:possible carbohydrate epitopes of KL-6 (MUC1) monoclonal antibody显示文摘 | Seko A Ohkura T Ideo H | | 0，，02： | 1 |
| 19 | The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity显示文摘 | Seko A Ishizuka I | 2003 | Glycobiology2003，13，10： | 1 |
| 20 | 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: A novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity显示文摘 | Umashankar Das Masami Kawase Hiroshi Sakagami Atsushi Ideo Jun Shimada Joseph Molnár Zoltán Baráth Zsuzsanna Bata Jonathan R. Dimmock | 2007 | Bioorganic & Medicinal Chemistry2007，，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员